Reconstruction and Analysis of Gene Networks of Human Neurotransmitter Systems Reveal Genes with Contentious Manifestation for Anxiety, Depression, and Intellectual Disabilities.


Journal

Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097

Informations de publication

Date de publication:
11 09 2019
Historique:
received: 12 08 2019
revised: 06 09 2019
accepted: 09 09 2019
entrez: 14 9 2019
pubmed: 14 9 2019
medline: 17 1 2020
Statut: epublish

Résumé

The study of the biological basis of anxiety, depression, and intellectual disabilities in humans is one of the most actual problems of modern neurophysiology. Of particular interest is the study of complex interactions between molecular genetic factors, electrophysiological properties of the nervous system, and the behavioral characteristics of people. The neurobiological understanding of neuropsychiatric disorders requires not only the identification of genes that play a role in the molecular mechanisms of the occurrence and course of diseases, but also the understanding of complex interactions that occur between these genes. A systematic study of such interactions obviously contributes to the development of new methods of diagnosis, prevention, and treatment of disorders, as the orientation to allele variants of individual loci is not reliable enough, because the literature describes a number of genes, the same alleles of which can be associated with different, sometimes extremely different variants of phenotypic traits, depending on the genetic background, of their carriers, habitat, and other factors. In our study, we have reconstructed a series of gene networks (in the form of protein-protein interactions networks, as well as networks of transcription regulation) to build a model of the influence of complex interactions of environmental factors and genetic risk factors for intellectual disability, depression, and other disorders in human behavior. A list of candidate genes whose expression is presumably associated with environmental factors and has potentially contentious manifestation for behavioral and neurological traits is identified for further experimental verification.

Sections du résumé

BACKGROUND
The study of the biological basis of anxiety, depression, and intellectual disabilities in humans is one of the most actual problems of modern neurophysiology. Of particular interest is the study of complex interactions between molecular genetic factors, electrophysiological properties of the nervous system, and the behavioral characteristics of people. The neurobiological understanding of neuropsychiatric disorders requires not only the identification of genes that play a role in the molecular mechanisms of the occurrence and course of diseases, but also the understanding of complex interactions that occur between these genes. A systematic study of such interactions obviously contributes to the development of new methods of diagnosis, prevention, and treatment of disorders, as the orientation to allele variants of individual loci is not reliable enough, because the literature describes a number of genes, the same alleles of which can be associated with different, sometimes extremely different variants of phenotypic traits, depending on the genetic background, of their carriers, habitat, and other factors.
RESULTS
In our study, we have reconstructed a series of gene networks (in the form of protein-protein interactions networks, as well as networks of transcription regulation) to build a model of the influence of complex interactions of environmental factors and genetic risk factors for intellectual disability, depression, and other disorders in human behavior.
CONCLUSION
A list of candidate genes whose expression is presumably associated with environmental factors and has potentially contentious manifestation for behavioral and neurological traits is identified for further experimental verification.

Identifiants

pubmed: 31514272
pii: genes10090699
doi: 10.3390/genes10090699
pmc: PMC6770977
pii:
doi:

Substances chimiques

Neurotransmitter Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1714-22
pubmed: 21609749
Epilepsy Res. 2003 Mar;53(3):255-8
pubmed: 12694935
Epilepsia. 2005 May;46(5):643-7
pubmed: 15857428
Pharmacogenet Genomics. 2007 Mar;17(3):217-20
pubmed: 17460550
Neurology. 2007 Feb 6;68(6):409-14
pubmed: 17283313
PLoS One. 2014 Sep 30;9(9):e108718
pubmed: 25268956
Am Psychol. 2014 Apr;69(3):249-68
pubmed: 24750075
JAMA. 2009 Jun 17;301(23):2462-71
pubmed: 19531786
J Alzheimers Dis. 2011;23(3):399-409
pubmed: 21116050
Psychiatry Res. 2018 Dec;270:769-774
pubmed: 30551323
Eur Neuropsychopharmacol. 2012 Apr;22(4):239-58
pubmed: 22137564
Nature. 2015 Oct 1;526(7571):75-81
pubmed: 26432246
Neuroreport. 1997 Mar 24;8(5):1235-7
pubmed: 9175120
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Bioinformatics. 2015 Sep 15;31(18):3075-7
pubmed: 25964630
J Neural Transm (Vienna). 2009 Oct;116(10):1193-200
pubmed: 19578924
Pharmacogenet Genomics. 2006 Apr;16(4):297-306
pubmed: 16538176
J Neurosci. 1999 Dec 1;19(23):10494-501
pubmed: 10575045
Nucleic Acids Res. 2019 Jan 8;47(D1):D786-D792
pubmed: 30304474
Nucleic Acids Res. 2005 Jan 1;33(Database issue):D433-7
pubmed: 15608232
Psychiatry Clin Neurosci. 2007 Feb;61(1):3-19
pubmed: 17239033
Epilepsy Res. 2007 Feb;73(2):192-8
pubmed: 17125969
Seizure. 2006 Jan;15(1):67-72
pubmed: 16386926
Pharmacogenomics. 2006 Sep;7(6):813-8
pubmed: 16981842
Pharmacogenetics. 1996 Jun;6(3):243-50
pubmed: 8807664
Brain. 2005 Aug;128(Pt 8):1832-40
pubmed: 15888540
PLoS One. 2012;7(10):e46335
pubmed: 23071556
Pharmacogenomics. 2005 Jun;6(4):411-7
pubmed: 16004559
BMC Psychiatry. 2019 Jun 3;19(1):166
pubmed: 31159756
J Intellect Disabil Res. 2019 May;63(5):408-417
pubmed: 30588708
Pharmacogenomics. 2006 Jun;7(4):551-61
pubmed: 16753003
Am J Med Genet B Neuropsychiatr Genet. 2004 Jul 1;128B(1):61-4
pubmed: 15211633
Mol Autism. 2013 Oct 03;4(1):36
pubmed: 24090431
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nucleic Acids Res. 2018 Jan 4;46(D1):D252-D259
pubmed: 29140464
Epilepsy Res. 2008 Jul;80(1):42-6
pubmed: 18436433
Biol Psychiatry. 2013 Nov 15;74(10):727-33
pubmed: 23764453
Epilepsy Res. 2008 Oct;81(2-3):220-4
pubmed: 18672349
Genet Mol Res. 2016 Feb 19;15(1):null
pubmed: 26909988
PLoS One. 2015 Mar 16;10(3):e0119743
pubmed: 25775400
Int J Dermatol. 2011 Feb;50(2):221-4
pubmed: 21244392
Curr Opin Pharmacol. 2002 Feb;2(1):23-33
pubmed: 11786305
Front Psychiatry. 2018 Dec 04;9:655
pubmed: 30564155
Epilepsy Res. 2005 Aug-Sep;66(1-3):59-62
pubmed: 16105728
Am J Psychiatry. 2018 Jan 1;175(1):15-27
pubmed: 28969442
Eur J Neurosci. 2014 Jun;39(11):1982-99
pubmed: 24809619
Child Adolesc Psychiatry Ment Health. 2016 May 19;10:10
pubmed: 27200107
Epilepsia. 2010 Apr;51(4):686-9
pubmed: 20074235
Nucleic Acids Res. 2015 Jan;43(Database issue):D76-81
pubmed: 25262351
J Affect Disord. 2015 Sep 01;183:156-8
pubmed: 26005777
Epilepsy Res. 2009 Jul;85(1):114-7
pubmed: 19394799
PLoS One. 2019 Jul 30;14(7):e0219888
pubmed: 31361768

Auteurs

Roman Ivanov (R)

Institute of Cytology and Genetics SB RAS, 630090 Novosibirsk, Russia. ivanov.romanart@yandex.ru.
Novosibirsk State University, 630090 Novosibirsk, Russia. ivanov.romanart@yandex.ru.

Vladimir Zamyatin (V)

Institute of Cytology and Genetics SB RAS, 630090 Novosibirsk, Russia. zamyatin@bionet.nsc.ru.
Novosibirsk State University, 630090 Novosibirsk, Russia. zamyatin@bionet.nsc.ru.

Aleksandra Klimenko (A)

Institute of Cytology and Genetics SB RAS, 630090 Novosibirsk, Russia. klimenko@bionet.nsc.ru.
Novosibirsk State University, 630090 Novosibirsk, Russia. klimenko@bionet.nsc.ru.

Yury Matushkin (Y)

Institute of Cytology and Genetics SB RAS, 630090 Novosibirsk, Russia. mat@bionet.nsc.ru.
Novosibirsk State University, 630090 Novosibirsk, Russia. mat@bionet.nsc.ru.

Alexander Savostyanov (A)

Institute of Cytology and Genetics SB RAS, 630090 Novosibirsk, Russia. Alexander.Savostyanov@gmail.com.
Novosibirsk State University, 630090 Novosibirsk, Russia. Alexander.Savostyanov@gmail.com.
Institute of Physiology and Basic Medicine SB RAMS, 630117 Novosibirsk, Russia. Alexander.Savostyanov@gmail.com.

Sergey Lashin (S)

Institute of Cytology and Genetics SB RAS, 630090 Novosibirsk, Russia. lashin@bionet.nsc.ru.
Novosibirsk State University, 630090 Novosibirsk, Russia. lashin@bionet.nsc.ru.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH